Endometrial Ablation Market (2026 - 2033)

Endometrial Ablation Market Summary

The global endometrial ablation market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.4 billion in 2026 to USD 2.0 billion by 2033, at a CAGR of 5.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 31.7% in 2025. This can be attributed to the increasing demand for endometrial ablation devices owing to the rising prevalence of gynecological disorders, such as PCOD, and menorrhagia, and rising public awareness about the procedure.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Key Market Trends & Insights

• By method: Radiofrequency ablation segment led the market with the largest revenue share of 56.1% in 2025.
• By end use: Clinics segment led the market with the largest revenue share of 53.3% in 2025.

Regional Highlights

• Largest regional market: North America (31.7% revenue share, 2025)
• Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
• By country: The U.S. held the largest market share in 2025.

Market Size & Forecast

• Market size in 2025: USD 1.3 Billion
• Estimated market size in 2026: USD 1.4 Billion
• Projected market size by 2033: USD 2.0 Billion
• CAGR (2026-2033): 5.2%

Furthermore, the competitive advantage of endometrial ablation over other surgical procedures, such as minimal invasiveness, is expected to boost the demand for devices in the coming years. Endometrial ablation is a minimally invasive procedure that removes the inner lining of the uterus to treat heavy menstrual bleeding. The global endometrial ablation market is experiencing significant growth, driven by several key factors. The rising prevalence of gynecological disorders, such as PCOS and abnormal uterine bleeding, has led to an increased demand for less invasive treatment options. Women are seeking alternatives to traditional surgeries that offer quicker recovery times and less discomfort. This patient-centered approach aligns with the global trend towards minimally invasive medical interventions, improving overall quality of life for those affected by these conditions.

To learn more about this report, Download Free Sample Report

The growing percentage of patients affected by menorrhagia, also known as heavy or abnormal menstrual bleeding, is anticipated to boost market growth during the forecast period. Heavy menstrual bleeding (AUB) affects 20-30% of women annually, with 53 per 1,000 women experiencing it each year. Some of its causes include fibroids, polyps, coagulopathies (e.g., 13% of women with AUB have Von Willebrand disease), and hormonal disorders. Treatments include endometrial ablation, which can significantly reduce bleeding in many cases.

Women's coverage plans are one of the primary elements projected to drive industry growth in developed countries. For instance, in India, numerous tax benefits and exemptions are available to women under various sections of the income tax legislation; one is the income tax deduction, which can be claimed on premiums paid for health insurance policies. Such initiatives concerning women’s health may increase the adoption of treatment options available for them, including endometrial ablation, thus boosting the market growth.

Furthermore, the market is benefiting from growing awareness about endometrial ablation procedures and a shift in patient preferences. As information becomes more readily available through healthcare professionals and online resources, women are becoming more informed about their treatment options. This empowerment has led to a preference for procedures like endometrial ablation, which offers shorter hospital stays, reduced pain, and faster recovery compared to traditional surgeries. The improved patient experience associated with these procedures has contributed to their increasing popularity.

Market Dynamics

The endometrial ablation market is experiencing steady growth, driven by the increasing prevalence of abnormal uterine bleeding (AUB), rising demand for minimally invasive gynecological procedures, growing awareness of uterus-preserving treatment options, and continuous technological advancements in endometrial ablation systems. The market is further supported by the increasing incidence of uterine disorders such as menorrhagia and fibroids, a growing preference for outpatient and office-based procedures, an expanding middle-aged female population, and improved access to advanced gynecological care across both developed and emerging healthcare markets. Endometrial ablation technologies enable hospitals, ambulatory surgery centers (ASCs), specialty gynecology clinics, and office-based practices to effectively treat excessive menstrual bleeding by destroying or removing the endometrial lining, thereby reducing or eliminating menstrual flow while avoiding hysterectomy in appropriately selected patients. Endometrial ablation devices are widely utilized for the treatment of abnormal uterine bleeding (AUB), particularly heavy menstrual bleeding (menorrhagia) in women who have completed childbearing and have not responded adequately to medical therapy.

Analyst Perspective

The global endometrial ablation market is positioned at the intersection of evolving women's healthcare needs, increasing adoption of minimally invasive gynecological procedures, and continuous technological advancements in endometrial ablation systems. The market is primarily driven by the rising prevalence of abnormal uterine bleeding (AUB) and heavy menstrual bleeding (HMB), particularly among women in the perimenopausal age group, along with the growing preference for uterus-preserving treatment options over conventional hysterectomy. Increasing awareness regarding women's reproductive health, improving access to gynecological care, and expanding availability of minimally invasive treatment options are creating significant growth opportunities for medical device manufacturers, hospitals, ambulatory surgery centers (ASCs), and specialized gynecology clinics. Furthermore, the growing global burden of obesity, uterine fibroids, hormonal imbalances, adenomyosis, and other gynecological conditions associated with excessive menstrual bleeding continues to expand the eligible patient population for endometrial ablation procedures. The market is further supported by the increasing shift toward outpatient and office-based gynecological procedures, driven by shorter recovery times, reduced healthcare costs, lower risk of surgical complications, and improved patient satisfaction compared to traditional surgical interventions.

Method Insights

Based on method, the radiofrequency ablation segment led the market with the largest revenue share of 56.1% in 2025. The growth is driven by the product’s convenience, speed of treatment, efficacy, and cost-efficiency compared to other ablation devices. In addition, the growth is further boosted by its convenience, rapid treatment process, high effectiveness, cost-efficiency, and widespread accessibility. These attributes make it an appealing option for both patients and healthcare providers. Furthermore, the increasing number of regulatory approvals for advanced devices is accelerating the expansion of this market segment. For instance, in February 2023, Hologic Inc. secured approval for its NovaSure V5 global endometrial ablation device in Canada and Europe. This next-generation device incorporates innovative features designed to enhance patient outcomes and procedural efficiency, contributing to its adoption across these regions.

The cryoablation segment is expected to grow at a CAGR of 5.4% from 2025 to 2030, owing to technological advancements that enhance precision and effectiveness. Its ability to treat complex cases with minimal tissue damage is particularly appealing. In addition, the procedure's adaptability to various clinical settings and compatibility with existing infrastructure contribute to its adoption. Furthermore, as healthcare systems focus on innovative treatments, cryoablation's unique benefits are driving its expansion.

End Use Insights

Based on end use, the clinics segment led the market with the largest revenue share of 53.3% in 2025, primarily driven by the implementation of innovative technologies for treating menorrhagia, increasing awareness about the use of endometrial ablation devices, expanding clinical trials on endometrial ablation methods, and increased government research allocations for the widespread availability of healthcare devices. Furthermore, the rising availability of advanced devices in clinics, coupled with increasing awareness about minimally invasive treatments, contributes to their expansion. Moreover, the convenience of localized care and shorter procedure times further solidify clinics as a preferred choice for endometrial ablation procedures.

To learn more about this report, Download Free Sample Report

The hospitals segment is expected to grow at a CAGR of 5.5% over the forecast period. This can be attributed to a rise in the number of patients being hospitalized for gynecological disorders, as hospitals provide excellent care as well as reimbursements. In addition, hospitals possess advanced treatment devices, which contributes to the expansion of this segment. Furthermore, due to the ease of managing any problems that may develop during surgical procedures and the availability of a wide range of treatment options in the facility, hospitals see a substantially higher inflow of patients for gynecological treatments than other healthcare settings.

Regional Insights

North America dominated the endometrial ablation market with the largest revenue share of 31.7% in 2025, attributed to rising cases of gynecological disorders, the presence of key market players, and rising preference for minimally invasive surgical procedures. In addition, increasing awareness about minimally invasive procedures and the availability of reimbursement policies are encouraging more patients to opt for endometrial ablation. Furthermore, the presence of leading market players and government initiatives promoting affordable healthcare further accelerate growth. Moreover, the rising adoption of outpatient procedures and technological advancements in ablation devices make North America a dominant region in the global market.

To learn more about this report, Download Free Sample Report

U.S. Endometrial Ablation Market Trends

The endometrial ablation market in the U.S. held the largest share in the North America region in 2025, driven by a large patient pool suffering from gynecological conditions, such as menorrhagia, affecting millions annually. High disposable incomes and comprehensive insurance coverage make this procedure more accessible to patients. In addition, the introduction of next-generation devices by key industry players and government support through policies like the Affordable Care Act enhance market expansion. Furthermore, growing awareness campaigns and precision medicine initiatives are improving treatment accessibility, solidifying the U.S. as a leader in this segment.

Asia Pacific Endometrial Ablation Market Trends

The Asia Pacific endometrial ablation market is expected to grow at the fastest CAGR of 5.6% over the forecast period. A growing prevalence of gynecological disorders, coupled with an expanding middle-class population, drives demand for cost-effective procedures. Improved access to healthcare facilities and government initiatives supporting advanced medical technologies further contribute to market growth.

The endometrial ablation market in China led rhea Asia Pacific market and held the largest revenue share in 2024, primarily driven by its large population base and increasing cases of gynecological disorders such as abnormal uterine bleeding. In addition, rising disposable incomes and improvements in healthcare infrastructure are enabling greater access to advanced treatments. Furthermore, government efforts to modernize medical facilities and promote minimally invasive procedures are further fueling demand. Moreover, local manufacturers developing affordable ablation devices are enhancing accessibility, while growing patient awareness contributes to the adoption of this procedure across both urban and rural regions.

Europe Endometrial Ablation Market Trends

The Europe endometrial ablation market is expected to grow significantly over the forecast period, driven by a robust healthcare system and rising incidences of gynecological conditions such as menorrhagia. In addition, increased adoption of innovative technologies, such as radiofrequency ablation, enhances procedural efficiency and patient outcomes. Favorable reimbursement policies across countries such as Germany, France, and the UK make these treatments more accessible. Furthermore, growing awareness campaigns by healthcare providers and support from regulatory bodies for advanced devices contribute to market expansion.

Key Endometrial Ablation Company Insights

Key companies in the global endometrial ablation industry include Medtronic, The Cooper Companies, Inc., Boston Scientific Corporation, and others. These players are employing strategies focused on innovation, expansion, and collaboration to strengthen their market position. In addition, they are investing in research and development to introduce advanced devices with enhanced safety and efficiency. Furthermore, partnerships and acquisitions are being pursued to expand geographical reach and product portfolios.

• Medtronic manufactures advanced medical devices and minimally invasive technologies designed to address gynecological conditions like heavy menstrual bleeding. Operating within the broader medical device industry, the company focuses on providing cutting-edge ablation systems that improve patient outcomes. Its products are widely utilized in hospitals, clinics, and outpatient settings, emphasizing efficiency, safety, and precision to meet the growing demand for minimally invasive procedures.

• Boston Scientific Corporation develops and manufactures medical devices for multiple therapeutic areas, including gynecology. The company provides advanced ablation devices for effectively treating abnormal uterine bleeding. Operating within the medical technology segment, Boston Scientific focuses on delivering innovative solutions that enhance procedural outcomes and patient care.

Key Endometrial Ablation Companies:

The following are the leading companies in the endometrial ablation market.

• Medtronic

• The Cooper Companies, Inc.

• Boston Scientific Corporation

• Johnson & Johnson Service Inc.

• Olympus Corporation

• Richard Wolf GmbH

• AngioDynamics

• Hologic, Inc.

• Minerva Surgical, Inc.

Recent Developments

• In November 2024, Olympus Corporation of the Americas showcased its comprehensive range of gynecological solutions at the AAGL World Congress. The display included hysteroscopy systems featuring Plasma Hysteroscopic Resection and Vaporization Electrodes, and the VERSAPOINT II Bipolar Electrosurgery System. These systems can be utilized in procedures such as Endometrial ablation.

• In October 2024, Minerva Surgical, partnered with Blackmaple Group to offer minimally invasive gynecologic technologies to WHAAPA physician members. The agreement includes the Minerva ES Ablation System and Medical Endoscopy Image Processing System for detecting and treating abnormal uterine bleeding (AUB).

Global Endometrial Ablation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global endometrial ablation market report based on product, end use, and region:

To learn more about this report, Download Free Sample Report

• Method Outlook (Revenue, USD Million, 2021 - 2033)

  • Cryoablation 

  • Radiofrequency ablation

  • Hydrothermal ablation

  • Thermal Balloon

  • Microwave energy

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals

  • Clinics

  • Ambulatory Centers

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The endometrial ablation market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each agriculture endometrial ablation quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations